Aristotle Capital Boston’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.5M | Sell |
|
|||||
|
2025
Q1 | $28.6M | Sell |
|
|||||
|
2024
Q4 | $38.9M | Sell |
|
|||||
|
2024
Q3 | $37.2M | Sell |
|
|||||
|
2024
Q2 | $32.2M | Buy |
|
|||||
|
2024
Q1 | $38.9M | Sell |
|
|||||
|
2023
Q4 | $33.6M | Sell |
|
|||||
|
2023
Q3 | $32.8M | Buy |
|
|||||
|
2023
Q2 | $34.9M | Buy |
|
|||||
|
2023
Q1 | $41.9M | Buy |
|
|||||
|
2022
Q4 | $40.2M | Sell |
|
|||||
|
2022
Q3 | $39.2M | Sell |
|
|||||
|
2022
Q2 | $36.7M | Buy |
|
|||||
|
2022
Q1 | $40.7M | Sell |
|
|||||
|
2021
Q4 | $37.5M | Sell |
|
|||||
|
2021
Q3 | $35.2M | Buy |
|
|||||
|
2021
Q2 | $32.7M | Buy |
|
|||||
|
2021
Q1 | $25.5M | Sell |
|
|||||
|
2020
Q4 | $25.7M | Sell |
|
|||||
|
2020
Q3 | $22.4M | Buy |
|
|||||
|
2020
Q2 | $24.4M | Buy |
|
|||||
|
2020
Q1 | $13.3M | Sell |
|
|||||
|
2019
Q4 | $18M | Buy |
|
|||||
|
2019
Q3 | $20.4M | Buy |
|
|||||
|
2019
Q2 | $3.44M | Buy |
|